News

One-third of popular social media articles about breast, colorectal, lung, and prostate cancer contained misleading or harmful information, according to a new study.

A national survey highlights rising vaccine hesitancy this flu season, with 37% of adults planning to skip flu and COVID-19 vaccines despite CDC recommendations.

New study found that increasing secukinumab dosage to 300 mg provides no significant benefit for ankylosing spondylitis patients who did not respond to 150 mg.

Inherited BRCA mutations may sharply increase the risk of early-onset multiple myeloma, according to new research.

Cannabis and hallucinogen use among adults continued to reach historic highs in 2023, according to the latest findings from the NIH-supported Monitoring the Future (MTF) survey.

Researchers from the University of Cincinnati, Ohio, suggest that increasing levels of the brain protein amyloid-β 42 may slow cognitive decline in Alzheimer’s disease.

Approval has been granted by the FDA for lebrikizumab-lbkz in treating moderate to severe atopic dermatitis in patients aged 12 and older.

Protective cells can be converted into tumor promoters after the immune system has been hijacked by cancer.